InvestorsHub Logo
Followers 285
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: Sixman post# 243693

Wednesday, 02/22/2017 1:07:32 PM

Wednesday, February 22, 2017 1:07:32 PM

Post# of 399506
Might want to reread some of those posts - I've only wavered in regards to SequestOx once - when I read Purdue's AdCom meeting comments regarding Avridi. Nasrat has met with the FDA to clarify how to take care of the problems I foresaw coming thereafter.

The softening has been in relation to the time in which the FDA takes to take care of drug approvals and the like. Even my previous conservative estimates of timeframes to approvals have come and gone.

Still, progress has proceeded and that cannot be denied.

Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News